{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:00:09Z","timestamp":1792072809643,"version":"4.4.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Standard high throughput screening projects using automated patch-clamp instruments often fail to grasp essential details of the mechanism of action, such as binding\/unbinding dynamics and modulation of gating. In this study, we aim to demonstrate that depth of analysis can be combined with acceptable throughput on such instruments. Using the microfluidics-based automated patch clamp, IonFlux Mercury, we developed a method for a rapid assessment of the mechanism of action of sodium channel inhibitors, including their state-dependent association and dissociation kinetics. The method is based on a complex voltage protocol, which is repeated at 1\u00a0Hz. Using this time resolution we could monitor the onset and offset of both channel block and modulation of gating upon drug perfusion and washout. Our results show that the onset and the offset of drug effects are complex processes, involving several steps, which may occur on different time scales. We could identify distinct sub-processes on the millisecond time scale, as well as on the second time scale. Automated analysis of the results allows collection of detailed information regarding the mechanism of action of individual compounds, which may help the assessment of therapeutic potential for hyperexcitability-related disorders, such as epilepsies, pain syndromes, neuromuscular disorders, or neurodegenerative diseases.<\/jats:p>","DOI":"10.3389\/fphar.2021.738260","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:28:20Z","timestamp":1632788900000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["An Advanced Automated Patch Clamp Protocol Design to Investigate Drug\u2014Ion Channel Binding Dynamics"],"prefix":"10.3389","volume":"12","author":[{"given":"Peter","family":"Lukacs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Pesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ty\u00e1s C.","family":"F\u00f6ldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Zboray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam V.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpad","family":"Mike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/bf00370302","article-title":"Riluzole Specifically Blocks Inactivated Na Channels in Myelinated Nerve Fibre","volume":"419","author":"Benoit","year":"1991","journal-title":"Pflugers Arch."},{"key":"B2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/164_2017_52","article-title":"Sodium Channelopathies of Skeletal Muscle","volume":"246","author":"Cannon","year":"2018","journal-title":"Handb. Exp. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.expneurol.2014.02.023","article-title":"Preclinical Evaluation of Marketed Sodium Channel Blockers in a Rat Model of Myotonia Discloses Promising Antimyotonic Drugs","volume":"255","author":"Desaphy","year":"2014","journal-title":"Exp. Neurol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/bph.15365","article-title":"The Mechanism of Non-blocking Inhibition of Sodium Channels Revealed by Conformation-Selective Photolabeling","volume":"178","author":"F\u00f6ldi","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"B5","first-page":"1055","article-title":"Block of the Rat Brain IIA Sodium Channel Alpha Subunit by the Neuroprotective Drug Riluzole","volume":"45","author":"Hebert","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"B6","first-page":"716","article-title":"Slow Binding of Phenytoin to Inactivated Sodium Channels in Rat Hippocampal Neurons","volume":"46","author":"Kuo","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fphar.2015.00210","article-title":"Different pH-Sensitivity Patterns of 30 Sodium Channel Inhibitors Suggest Chemically Different Pools along the Access Pathway","volume":"6","author":"Lazar","year":"2015","journal-title":"Front. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuropharm.2010.08.005","article-title":"Binding of Sodium Channel Inhibitors to Hyperpolarized and Depolarized Conformations of the Channel","volume":"60","author":"Lenkey","year":"2011","journal-title":"Neuropharmacology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1124\/mol.106.026419","article-title":"The Mechanism of Activity-Dependent Sodium Channel Inhibition by the Antidepressants Fluoxetine and Desipramine","volume":"70","author":"Lenkey","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e15568","DOI":"10.1371\/journal.pone.0015568","article-title":"Classification of Drugs Based on Properties of Sodium Channel Inhibition: A Comparative Automated Patch-Clamp Study","volume":"5","author":"Lenkey","year":"2010","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1089\/adt.2011.0375","article-title":"Validation of a Patch Clamp Screening Protocol that Simultaneously Measures Compound Activity in Multiple States of the Voltage-Gated Sodium Channel Nav1.2","volume":"9","author":"Liu","year":"2011","journal-title":"Assay Drug Dev. Technol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/0471141755.ph1114s65","article-title":"Electrophysiological Studies of Voltage-Gated Sodium Channels Using QPatch HT, an Automated Patch-Clamp System","volume":"65","author":"Liu","year":"2014","journal-title":"Curr. Protoc. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"8110","DOI":"10.1038\/s41598-018-26444-y","article-title":"Non-Blocking Modulation Contributes to Sodium Channel Inhibition by a Covalently Attached Photoreactive Riluzole Analog","volume":"8","author":"Lukacs","year":"2018","journal-title":"Sci. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/bs.ctm.2016.06.001","article-title":"Nav Channels in Damaged Membranes","volume":"78","author":"Morris","year":"2016","journal-title":"Curr. Top. Membr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"738460","DOI":"10.3389\/fphar.2021.738460","article-title":"Characterization of Compound-specific, Concentration-independent Biophysical Properties of Sodium Channel Inhibitor Mechanism of Action Using Automated Patch-Clamp Electrophysiology","volume":"12","author":"Pesti","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fphar.2011.00063","article-title":"Skeletal Muscle Na Channel Disorders","volume":"2","author":"Simkin","year":"2011","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neuropharm.2016.06.029","article-title":"Ranolazine vs Phenytoin: Greater Effect of Ranolazine on the Transient Na(+) Current Than on the Persistent Na(+) Current in central Neurons","volume":"110","author":"Terragni","year":"2016","journal-title":"Neuropharmacology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/bcp.12996","article-title":"Cell Membranes\u2026 and How Long Drugs May Exert Beneficial Pharmacological Activity In Vivo and How Long Drugs May Exert Beneficial Pharmacological Activity In Vivo","volume":"82","author":"Vauquelin","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.cell.2017.06.039","article-title":"Structure of the Nav1.4-\u03b21 Complex from Electric Eel","volume":"170","author":"Yan","year":"2017","journal-title":"Cell"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.738260\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T09:44:53Z","timestamp":1632908693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.738260\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":19,"alternative-id":["10.3389\/fphar.2021.738260"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.738260","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.05.451189","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]},"article-number":"738260"}}